ena-STUDY-INSTITUTO NACIONAL DE SALUD-07-02-2019-19:12:12:405-92
The rapid emergence and spread of multi-drug resistant Gram-negative bacteria has renewed interest in colistin as a last resort treatment.
There are multiplex chromosomal mutations associated with acquired colistin resistance; likewise, the recently mcr-1 plasmid-mediated colistin resistance gene described in China and shortly later was identified on all continents and in a wide variety of ecological niches.
There are multiplex chromosomal mutations associated with acquired colistin resistance; likewise, the recently mcr-1 plasmid-mediated colistin resistance gene described in China and shortly later was identified on all continents and in a wide variety of ecological niches.